BlackRock’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-187,833
| Closed | -$74.7K | – | 5633 |
|
|
2022
Q4 | $74.7K | Sell |
187,833
-125,089
| -40% | -$49.7K | ﹤0.01% | 5042 |
|
|
2022
Q3 | $245K | Sell |
312,922
-12,261
| -4% | -$9.6K | ﹤0.01% | 4836 |
|
|
2022
Q2 | $936K | Sell |
325,183
-709,012
| -69% | -$2.04M | ﹤0.01% | 4469 |
|
|
2022
Q1 | $6.49M | Sell |
1,034,195
-14,616
| -1% | -$91.7K | ﹤0.01% | 3733 |
|
|
2021
Q4 | $11.7M | Buy |
1,048,811
+122,632
| +13% | +$1.37M | ﹤0.01% | 3525 |
|
|
2021
Q3 | $15.1M | Buy |
926,179
+42,013
| +5% | +$686K | ﹤0.01% | 3413 |
|
|
2021
Q2 | $16.4M | Buy |
884,166
+445,730
| +102% | +$8.26M | ﹤0.01% | 3358 |
|
|
2021
Q1 | $6.61M | Buy |
438,436
+7,434
| +2% | +$112K | ﹤0.01% | 3749 |
|
|
2020
Q4 | $13.9M | Buy |
+431,002
| New | +$13.9M | ﹤0.01% | 3133 |
|